tyrosyltyrosine (Tyr-Tyr)

RN given refers to all-(L)-isomer
Also Known As:
Tyr-Tyr; L-tyrosyl-L-tyrosine; peptide tyrosine-tyrosine
Networked: 31 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results


1. Piguet, Olivier: 1 article (10/2015)
2. Kiernan, Matthew C: 1 article (10/2015)
3. Latheef, Sahar: 1 article (10/2015)
4. Hodges, John R: 1 article (10/2015)
5. Irish, Muireann: 1 article (10/2015)
6. Halliday, Glenda M: 1 article (10/2015)
7. Ahmed, Rebekah M: 1 article (10/2015)
8. Bartley, Lauren: 1 article (10/2015)
9. Iturrino, Johanna: 1 article (03/2015)
10. O'Neill, Jessica: 1 article (03/2015)

Related Diseases

1. Proteinuria
2. Neoplasms (Cancer)
01/01/2014 - "Peptide tyrosine-tyrosine combined with its receptors exhibits an anti-cancer potential in pancreatic cancer MiaPaCa-2 cell."
05/01/1991 - "The tumor cells revealed argyrophilia, and were positive for peptide tyrosine tyrosine (PYY) in the cytoplasm and for CEA in part of the luminal surface. "
09/15/1988 - "In the analysis of the hormonal substances coexpressed by CGA-positive cells, immunoreactive serotonin (SER) was found most frequently, and somatostatin (SS), gastrin (GAS), glucagon/glicentin (GLU/GLI), and peptide-tyrosine-tyrosine (PYY) like immunoreactivities were found in a few tumor cells. "
01/01/2015 - "Serum 25(OH)D and SNPs (n = 960) related to genes with relevance for skin pigmentation (tyrosinase [TYR], TYR-related protein 1 [TYRP1], dopachrome tautomerase [DCT], oculocutaneous albinism II [OCA2], two pore segment channel 2 [TPCN2], solute carrier family 24 A4 [SLC24A4], solute carrier family 45 A2 [SLC45A2], agouti signalling peptide [ASIP], cyclic AMP-dependent transcription factor [ATF1], microphthalmia-associated transcription factor [MITF], proopiomelanocortin [POMC], cAMP-dependent protein kinase catalytic subunit beta [PRKACB], cAMP-dependent protein kinase catalytic subunit gamma [PRKACG], cAMP-dependent protein kinase type I-alpha regulatory subunit [PRKAR1A], cAMP-dependent protein kinase type II-alpha regulatory subunit [PRKAR2A], cAMP-dependent protein kinase type II-beta regulatory subunit [PRKAR2B], tubulin beta-3 chain/melanocortin receptor 1 [TUBB3/MC1R], Cadherin-1 [CDH1], catenin beta 1 [CTNNB1], Endothelin 1 [EDN1], endothelin 3 [EDN3], endothelin receptor type B [EDNRB], fibroblast growth factor 2 [FGF2], KIT, KIT ligand [KITLG], nerve growth factor [NGF], interferon regulatory factor 4 [IRF4], exocyst complex component 2 [EXOC2], and tumor protein 53 [TP53]) were analyzed in a cohort of participants of the Ludwigshafen Risk and Cardiovascular Health Study (n = 2970). "
3. Bulimia Nervosa
4. Oculocutaneous Albinism (Albinism, Yellow Mutant)
5. Weight Loss (Weight Reduction)

Related Drugs and Biologics

1. Ghrelin
2. Monophenol Monooxygenase (Tyrosinase)
3. Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit
4. Microphthalmia-Associated Transcription Factor
5. Activating Transcription Factor 1
6. beta Catenin
7. Type 1 Melanocortin Receptor
8. Nerve Growth Factor (NGF)
9. Endothelin-3 (Endothelin 3)
10. Endothelin-1 (Endothelin 1)

Related Therapies and Procedures

1. Therapeutics
2. Electrodes (Electrode)